300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Pakistan
Madagascar
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Costa Rica
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Canada
Paraguay
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Ireland
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Marius Nacht, Founder & Anchor Investor at aMoon Fund

Marius Nacht

Founder & Anchor Investor @ aMoon Fund

Tel Aviv-yafo, Israel

Marius Nacht is a Series A investor at aMoon Fund in Tel Aviv-yafo focused on Artificial Intelligence and Machine Learning. Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point. Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.

Total investments:
34
Last investment:
Lead investor:
47%

Last updated:

Industries Marius Nacht invests in

Artificial IntelligenceMachine LearningHealth CareCyber SecurityMedical

Stages Marius Nacht invests in

Series ASeries BSeedVenture - Series UnknownAngel

Countries Marius Nacht invests in

IsraelUnited StatesGermanySwitzerland

Round sizes

Seed $3M–$120MSeries A $5M–$23MSeries B $8M–$83M

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$3M–$120M
Series A
$5M–$23M
Series B
$8M–$83M

Investment Focus

Industry

  • Artificial Intelligence 10 (29%)
  • Machine Learning 7 (21%)
  • Health Care 6 (18%)
  • Cyber Security 5 (15%)
  • Medical 4 (12%)
See all 65 industries →

Stage

  • Series A 13 (38%)
  • Series B 6 (18%)
  • Seed 5 (15%)
  • Venture - Series Unknown 5 (15%)
  • Angel 1 (3%)
See all 6 stages →

Country

  • Israel 14 (41%)
  • United States 9 (26%)
  • Germany 1 (3%)
  • Switzerland 1 (3%)

Investments

CompanyDescriptionRoundLinks
CPTx CPTx
CPTx develops single-stranded DNA products to neutralize viruses and address infectious diseases. $29M / Venture - Series Unknown / Sep 12, 2024
WaveBL WaveBL
WaveBL is a digital platform using proprietary blockchain technology to transfer electronically trade documents. The WaveBL solution enables the instant, encrypted, and authenticated transfer of electronic Bills of Lading and related trade documents. The platform complies with universal processes and regulations in use. The platform is designed tomeet the needs of all parties involved in trade, including shipping companies, agents, brokers, and banks. WaveBL has strong alliances with leading companies in global trade to drive faster digitalization and adoption. $37M / Series B / Jun 06, 2023
Wisdo Health Wisdo Health
Wisdo is an AI-powered Social Health platform harnessing the power of data and meaningful connections to improve health. $5M / Series A / Jan 05, 2023
CommonGround-AI CommonGround-AI
CommonGround-AI provides a new 3D video platform. $25M / Series A / Nov 30, 2022
Ultima Genomics Ultima Genomics
Ultima Genomics is unleashing the power of genomics at scale. Ultima Genomics drives the scale of genomic information to enable unprecedented advances in biology and improvements in human health. $600M / Venture - Series Unknown / May 31, 2022
BioGenCell BioGenCell
BioGenCell designs cellular therapies that treat blood flow problems in the limbs, a side effect of diabetes and heart disease. Its technology creates autologous cells, derived from the patients themselves, to repair themselves. Its lead product, BC1, uses the company's technology to treat blood vessel insufficiency that can cause multipleorgan failure in diabetic patients. Derived from the patient's own adult stem cells, its easy-to-use and cost-effective therapies can regenerate damaged tissues, with the eventual goal of treating a wide range of degenerative diseases including diabetes, heart failure, stroke, blindness, cancer, and immunological diseases. Its patented technology platform provides a comprehensive solution for most aspects of cellular therapy and supports rapid manufacturing and long-term storage (bio-banking) of therapeutic cellular products for use in patient treatment. $16M / Seed / May 09, 2022
WINT WINT
WINT - Water Intelligence developing advanced solutions for smart water management and control. The company detects and stops leaks at the source using Artificial Intelligence. It is used in commercial and industrial facilities, offices, homes, and apartments. It also prevents water damage caused by leaks, broken pipes or malfunctioning watersystems.WINT customers gain deep insights about their water use to identify water waste and reduce consumption by 25%. They manage water and detect leaks using artificial intelligence and pattern matching technologies, combining high accuracy metering with advanced data analytics. WINT solutions protect global real estate portfolios and homes by revealing leaks and identifying water savings opportunities.WINT was founded in 2011 and is headquartered in New York, USA. $15M / Series B / Jan 11, 2022
GrayMatters Health GrayMatters Health
GrayMatters Health delivers beyond the pill digital therapeutics for mental disorders through self-neuromodulation of brain processes. $10M / Series A / Jan 11, 2022
1E Therapeutics 1E Therapeutics
1E Therapeutics is a breakthrough, drug development company creating RNA-targeting therapeutics based on a proprietary drug design platform. $120M / Seed / Dec 08, 2021
TriEye TriEye
TriEye is the pioneer of mass-market, CMOS-based Short-Wave infrared (SWIR) sensing solutions. Based on advanced academic research, TriEye’s breakthrough and proprietary technology enables cost-effective, high-resolution image data and depth perception in all weather and lighting conditions. Founded in 2017, the company’s cutting-edge technologyallows perception systems to operate and deliver reliable image data and actionable information, while reducing expenditure by up to 1,000x the existing industry rates. $74M / Series B / Nov 10, 2021
See all 34 investments →

Co-Investors

aMoon Fund

About aMoon Fund

VC Fund · Ra'anana, Israel

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.

aMoon Fund Contacts

NameEmailPhoneSocials
Moshe Mor
Moshe Mor General Partner
Gur Roshwalb Managing Director
Itay Bengad
Itay Bengad Executive in Residence
Marius Nacht
Marius Nacht Founder & Anchor Investor
Michal Goren Miller
Michal Goren Miller Chief Legal Counsel & Chief Compliance Officer

Sign up to unlock verified contacts

Unlock Contacts

See all contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Pakistan
Madagascar
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Costa Rica
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Canada
Paraguay
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Ireland
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Marius Nacht invest in?

Marius Nacht invests primarily in Artificial Intelligence, Machine Learning and Health Care startups, most often at Series A and Series B stage. Most of the 34 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Marius Nacht's check size?

Marius Nacht typically joins rounds of $3M–$120M at Seed, $5M–$23M at Series A and $8M–$83M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Marius Nacht participates in.

How do I contact Marius Nacht?

Public channels for Marius Nacht include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Marius Nacht last invest?

The most recent investment recorded for Marius Nacht closed in Sep 2024. Shizune tracks 34 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Marius Nacht Marius Nacht Find email